BiotechTube
Beantown Biotech

Beantown Biotech

Woburn, United States· Est.
beantownbiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $27.2M

Overview

Beantown Biotech is a privately held, revenue-generating CRO providing outsourced drug discovery services from target validation through lead optimization. The company's core value proposition is delivering high-quality, client-focused research with rapid turnaround, supported by an experienced team of biologists and a 6,000-square-foot facility in Billerica, Massachusetts. Its business model is purely service-based, catering to biotech and pharmaceutical companies seeking to advance their pipelines without internal overhead. While it does not develop its own therapeutic assets, its success is tied to the robust outsourcing trends within the biopharma R&D sector.

Drug DiscoveryContract Research

Technology Platform

Integrated suite of biochemical and cell-based assay development, screening (HTS), high-content imaging, flow cytometry, and molecular biology capabilities, augmented by a strategic partnership for mass spectrometry services.

Funding History

3
Total raised:$27.2M
Series A$22M
Seed$2M
Seed$3.2M

Opportunities

The strong and growing trend of biopharma outsourcing, particularly from capital-efficient virtual and small biotechs, provides a steady stream of potential clients.
Its location in the Boston biotech hub offers unparalleled access to a dense network of innovative companies.
Expanding service capabilities through strategic partnerships, as demonstrated with mass spectrometry, allows it to address broader client needs without major capital expenditure.

Risk Factors

Revenue is highly susceptible to downturns in biotech funding, which can cause clients to reduce R&D spending.
The company operates in an intensely competitive CRO landscape with both large global players and niche specialists.
Its reputation and business depend entirely on consistently delivering high-quality, error-free data for clients, creating significant operational and reputational risk.

Competitive Landscape

Beantown Biotech competes in a crowded CRO market, facing competition from large, full-service global CROs (e.g., LabCorp, IQVIA, Charles River), other specialized discovery-focused CROs, and academic core facilities. Its differentiation is based on a client-partner model, deep biological expertise, and geographic proximity within the Boston ecosystem, rather than competing solely on scale or price.

More companies in Digital Health & Biotech SaaS →More companies in United States →